Skip to content

For US Healthcare Professionals Only

Prescribing Information
Patient Site
Vevye Logo Vevye Logo Contact Us

Access For all patients

Commercially eligible patients may receive their first prescription as low as $0*

VEVYE® Savings Program

Available Through Retail Pharmacies

  • Commercially insured patients may pay as little as $0*
  • 100% money back guarantee**
  • Visit getvevye.com to download a Patient Savings Card
Learn More

Benefits of Prescribing Through PhilRx

  • Eligible patients receive their first prescription as low as $0*
  • Prescriptions ship FREE right to your patient’s door
  • Assistance with initiating the prior authorization process
EMR Card Instructions Philrx Instruction Sheet

100% money-back guarantee**

time to try vevye

Connect with a representative to learn more.

Connect with a representative to learn more.

Contact Us

*PhilRx is a third-party vendor. By participating in the program, patients acknowledge that they currently meet the eligibility criteria. This program is only available for eligible commercially insured patients who are dispensed VEVYE by PhilRx or another participating pharmacy. This offer is not valid for patients with government insurance, including, but not limited to, Medicaid or Medicare. A patient’s out-of-pocket cost may be greater based on patient’s plan benefit design. Additional terms and conditions apply. All patients, including uninsured, commercially insured, and government-insured, may be eligible for manufacturer cash discount pricing subject to program terms and conditions for opt-out. These offers are available through any participating retail pharmacy, not just PhilRx.

**This offer is available on one fill only, and is valid only for eligible patients paying cash who do not have commercial or government insurance. This offer is not valid for patients with government insurance, including, but not limited to, Medicaid or Medicare. Contact Harrow at 833-442-7769 for information on how to apply for your money back guarantee. Additional terms and conditions apply.

INDICATION AND USAGE

VEVYE® (cyclosporine ophthalmic solution) 0.1% is indicated for the treatment of the signs and symptoms of dry eye disease.

IMPORTANT SAFETY INFORMATION

Warnings and Precautions

  • Potential for Eye Injury and Contamination – To avoid the potential for eye injury and/or contamination, patients should not touch the bottle tip to the eye or other surfaces.
  • Use with Contact Lenses – VEVYE should not be administered while wearing contact lenses. If contact lenses are worn, they should be removed prior to administration of the solution. Lenses may be reinserted 15 minutes following the administration of VEVYE.

Adverse Reactions

In clinical trials with 738 subjects receiving at least 1 dose of VEVYE, the most common adverse reactions were instillation site reactions (8%) and temporary decreases in visual acuity (3%).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
For additional information about VEVYE, please see the Full Prescribing Information.